Sonoscape Medical Corp.’s Net Profit Rose 30.7% in First Three Quarters of 2023

Sonoscape Medical Corp. (深圳开立生物医疗科技股份有限公司) (300633.SZ) reported a net profit of 320.6 million yuan in the first three quarters of 2023, up 30.7% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, up 17.3% year-on-year.

At the end of the reporting period, it had 3.7 billion yuan in total assets and 654.1 million yuan in total liabilities, with a liability-to-asset ratio of 17.6%.